Pharma EXPO 2015 will address regulatory trends.

Press Release Summary:



Taking place in Las Vegas, NV from September 28–30, Pharma EXPO 2015 will provide forum for manufacturers in pharmaceutical, nutraceutical, biopharmaceutical, and medical device sectors to learn about latest regulations. Educational opportunities will provide clarification as well as actionable insight and sophisticated technologies. Co-located with PMMI's PACK EXPO Las Vegas, combined event is projected to attract 30,000 attendees to see solutions presented by 2,000 suppliers.



Original Press Release:



Pharma EXPO Addresses Regulatory Trends



Las Vegas event will be home to solutions and insights to address traceability throughout the product lifecycle



Reston, Va. — In just over two years, pharmaceutical manufacturers must meet the Nov. 27, 2017, deadline of the Drug Supply Chain Security Act (DSCSA), which requires unique product identifiers on certain prescription drug packages. This measure is part of 2013’s Title II of the Drug Quality and Security Act (DQSA), a 10-year rollout of steps to prevent the counterfeiting of drugs distributed in the United States. To help pharmaceutical manufacturers comply with this and other regulations, Pharma EXPO 2015 (Sept. 28–30; Las Vegas Convention Center) will provide access to advanced solutions for the entire pharmaceutical lifecycle and a wide range of educational opportunities.



Co-produced by PMMI, The Association for Packaging and Processing Technologies, and the International Society for Pharmaceutical Engineering (ISPE), and co-located with PMMI’s PACK EXPO Las Vegas, Pharma EXPO will provide a forum where manufacturers in the pharmaceutical, nutraceutical, biopharmaceutical and medical device sectors can learn about the latest regulations, offering clarification as well as actionable insights and sophisticated technologies. Projections indicate the combined event will attract 30,000 attendees to see solutions presented by 2,000 suppliers.



“The Drug Supply Chain Security Act, along with other pharmaceutical regulations worldwide, places an increased emphasis on serialization and the interoperability of systems along the supply chain and in the pharmaceutical production process,” says Tom Egan, vice president, Industry Services, PMMI. “It is important for affected pharmaceutical manufacturers to ensure they are equipped to meet these new requirements and protect their supply chains – and patients – against counterfeiters.”



To help attendees keep up with the new provisions and address the challenges they bring forth, Pharma EXPO will provide excellent educational opportunities, including free 30-minute presentations at the Innovation Stage (Booth N-559). These sessions, conveniently located on the show floor, will present the latest information on breakthrough technologies and techniques for the pharmaceutical industry.



In addition, the Pharma EXPO conference program, organized by ISPE, will run daily during the show, and the designated track for Tuesday, Sept. 29, is Compliance Trends. Tuesday’s presentations will delve into serialization, track-and-trace, risk management, cleaning validation and incident investigation. The world-class sessions include “Serialization and Track & Trace: From Theory to Practical Application Success Including Global Trends,” led by Marcelo De Oliveira of NORDIKA. This presentation will address the urgent need to develop strategies and implement actions to cover new and future requirements, comply with laws and receive benefits from regulations.



To register for Pharma EXPO, visit www.pharmaexpo.com. Registration is $30 through Sept. 14. Starting Sept. 15, registration increases to $100. Separate fees apply to the Pharma EXPO conference program. Discounted conference costs through Sept. 14 are $90 for a single session, $145 for a single-day pass and $350 for a full-conference pass. After Sept. 14, the rates increase to $140 for a single session, $220 for a single-day pass and $500 for a full-conference pass.



About PMMI

PMMI, The Association for Packaging and Processing Technologies is a trade association representing more than 700 companies that provide a full range of processing and packaging machinery, materials, components and containers. PMMI actively brings buyers and sellers together through initiatives such as packexpo.com, educational programs and world-class events, connecting participants in the processing and packaging supply chain with their customers around the world. PMMI produces the PACK EXPO portfolio of trade shows that include PACK EXPO Las Vegas 2015 (Sept. 28–30, Las Vegas Convention Center); Pharma EXPO, co-located with PACK EXPO Las Vegas 2015; EXPO PACK México 2016, May 17–20, (Mexico City, Expo Bancomer Santa Fe); PACK EXPO International 2016, Nov. 6–9 (McCormick Place, Chicago, Ill.); Pharma EXPO, co-located with PACK EXPO International 2016; PACK EXPO East 2017, Feb. 27–March 1, (Pennsylvania Convention Center, Philadelphia) and EXPO PACK Guadalajara 2017, June 13–15, 2017(Guadalajara, Jalisco, Mexico). PMMI owns PMMI Media Group, a market-leading B2B media company that produces information for processing and packaging professionals, bringing together solution providers and end-users and facilitating connectivity throughout the supply chain. Its world class media brands Packaging World, Automation World, Healthcare Packaging, Contract Packaging and Packaging + Processing OEM are proven leaders in covering this diverse and dynamic marketplace, and its digital products incorporate leading edge media technologies to deliver informed, actionable business intelligence to the industry. PMMI Media Group also produces The Automation Conference, an annual education and networking forum, taking place in Chicago each spring.



About ISPE

ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit www.ISPE.org for more information.



Contact Information:

Christina Tenuta

ABI

29 Broadway

Suite 1300

New York, NY 10006

212.529.4500

ctenuta@abipr.com

All Topics